Abstract:Background: Transient receptor potential channels (TRPs) have been demonstrated to take on functions in pancreatic adenocarcinoma (PAAD) biology. However, little data are available that validate the potential of TRP in a clinical translational setting. Methods: A TRPs-related gene signature was constructed based on the Cox regression using a TCGA-PAAD cohort and receiver operating characteristic (ROC) was used to evaluate the predictive ability of this model. Core genes of the signature were screened by a protein-to-protein interaction (PPI) network, and expression validated by two independent datasets. The mutation analysis and gene set enrichment analysis (GSEA) were conducted. Virtual interventions screening was performed to discover substance candidates for the identified target genes. Results: A four TRPs-related gene signature, which contained MCOLN1, PKD1, TRPC3, and TRPC7, was developed and the area under the curve (AUC) was 0.758. Kaplan–Meier analysis revealed that patients with elevated signature score classify as a high-risk group featuring significantly shorter recurrence free survival (RFS) time, compared to the low-risk patients (p < 0.001). The gene prediction model also had a good predictive capability for predicting shortened overall survival (OS) and disease-specific survival (DSS) (AUC = 0.680 and AUC = 0.739, respectively). GSEA enrichment revealed the core genes of the signature, TRPC3 and TRPC7, were involved in several cancer-related pathways. TRPC3 mRNA is elevated in cancer tissue compared to control tissue and augmented in tumors with lymph node invasion compared to tumors without signs of lymph node invasion. Virtual substance screening of FDA approved compounds indicates that four small molecular compounds might be potentially selective not only for TRPC3 protein but also as a potential binding partner to TRPC7 protein. Conclusions: Our computational pipeline constructed a four TRP-related gene signature that enables us to predict clinical prognostic value of hitherto unrecognized biomarkers for PAAD. Sensory ion channels TRPC3 and TRPC7 could be the potential therapeutic targets in pancreatic cancer and TRPC3 might be involved in dysregulating mitochondrial functions during PAAD genesis.

TRPM7 and TRPM8 Ion Channels in Pancreatic Adenocarcinoma: Potential Roles as Cancer Biomarkers and Targets

TRPM2 Promotes the Proliferation and Invasion of Pancreatic Ductal Adenocarcinoma

Genetic and Immune Identification and Functional Analysis of TRPM8 As a Potential Biomarker for Pancreatic Adenocarcinoma Proliferation

Identification of the Role of TRPM8 in Glioblastoma and Its Effect on Proliferation, Apoptosis and Invasion of the U251 Human Glioblastoma Cell Line

The Clinnical Significance of TRPM8 Ion Channels Over-Expressed in Pancreatic Cancer

Oncogenic role and therapeutic target of transient receptor potential melastatin 7 channel in malignancy

Sensory Ion Channel Candidates Inform on the Clinical Course of Pancreatic Cancer and Present Potential Targets for Repurposing of FDA-Approved Agents

Therapeutic potential of TRPM8 channels in cancer treatment

TRPM7 Ion Channel: Oncogenic Roles and Therapeutic Potential in Breast Cancer

The LCK-14-3-3ζ-TRPM8 Axis Regulates TRPM8 Function/assembly and Promotes Pancreatic Cancer Malignancy

Transient receptor potential (TRP) channels, promising potential diagnostic and therapeutic tools for cancer

On the modulation of TRPM channels: Current perspectives and anticancer therapeutic implications

N-glycosylation of the transient receptor potential melastatin 8 channel is altered in pancreatic cancer cells

Comprehensive Pan-Cancer Analysis of TRPM8 in Tumor Metabolism and Immune Escape

The TRPM7 Channel Reprograms Cellular Glycolysis to Drive Tumorigenesis and Angiogenesis

The Role of TRPM7 in Oncogenesis

Role of TRPM7 kinase in cancer

TRPV6 as A Target for Cancer Therapy

A novel methylated cation channel TRPM4 inhibited colorectal cancer metastasis through Ca<SUP>2+</SUP>/Calpain-mediated proteolysis of FAK and suppression of PI3K/Akt/mTOR signaling pathway

Stimulating TRPM7 suppresses cancer cell proliferation and metastasis by inhibiting autophagy

TRPM8 facilitates proliferation and immune evasion of esophageal cancer cells